A PROSPECTIVE, RANDOMIZED, OPEN-LABEL, COMPARATIVE TRIAL OF DIDEOXYINOSINE (DDI) VERSUS DIDEOXYCYTIDINE (DDC) IN HIV-INFECTED PATIENTS WHO ARE INTOLERANT OF OR WHO HAVE FAILED ZIDOVUDINE (AZT) THERAPY: